Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network

Buchbinder, Rachelle (Primary Chief Investigator (PCI))
Maher, Chris Gerard (Chief Investigator (CI))
March, Lynette (Chief Investigator (CI))
Day, Richard O. (Chief Investigator (CI))
Hinman, Rana Shane (Chief Investigator (CI))
Harris, Ian Andrew (Chief Investigator (CI))
Ferreira, Manuela Loureiro (Chief Investigator (CI))
Glaziou, Paul (Chief Investigator (CI))
Green, Sally (Chief Investigator (CI))
Billot, Laurent (Chief Investigator (CI))
Latimer, Jane (Associate Investigator (AI))
Whittle, Samuel Lawrence (Associate Investigator (AI))
Cicuttini, Flavia (Associate Investigator (AI))
Hill, Catherine Louise (Associate Investigator (AI))
Lin, Christine (Associate Investigator (AI))
Taylor, William John (Associate Investigator (AI))
Hunter, David John (Associate Investigator (AI))
Harris, Anthony (Associate Investigator (AI))
Winzenberg, Tania Maree (Associate Investigator (AI))
McAuley, James (Associate Investigator (AI))

Project: Research

Project Description

NHMRC Centre of Research Excellence

Short title	ANZMUSC Clinical Trial Network
Acronym	ANZMUSC
Status	Finished
Effective start/end date	1/01/18 → 31/12/22

5 Article
2 Review Article

Australian recommendations on perioperative use of disease-modifying anti-rheumatic drugs in people with inflammatory arthritis undergoing elective surgery
Buchbinder, R., Glennon, V., Johnston, R. V., Brennan, S. E., Fong, C., Edward May, S., O'Neill, S., Smitham, P., Trevena, L., Whittaker, G., Wluka, A. & Whittle, S. L., Jul 2023, In: Internal Medicine Journal. 53, 7, p. 1248-1255 8 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

2 Citations (Scopus)
Prioritization of clinical questions for the Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis
Whittle, S. L., Glennon, V. & Buchbinder, R., Dec 2023, In: International Journal of Rheumatic Diseases. 26, 12, p. 2410-2418 9 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

4 Citations (Scopus)
Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)
Taylor, W. J., Willink, R., O Connor, D. A., Patel, V., Bourne, A., Harris, I. A., Whittle, S. L., Richards, B., Clavisi, O., Green, S., Hinman, R. S., Maher, C. G., Cahill, A., McPherson, A., Hewson, C., May, S. E., Walker, B., Robinson, P. C., Ghersi, D. & Fitzpatrick, J. & 5 others, Winzenberg, T., Fallon, K., Glasziou, P., Billot, L. & Buchbinder, R., Mar 2023, In: PLoS ONE. 18, 3, 17 p., e0281308.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

3 Citations (Scopus)

Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network

Project Details

Project Description

Research output

Australian recommendations on perioperative use of disease-modifying anti-rheumatic drugs in people with inflammatory arthritis undergoing elective surgery

Prioritization of clinical questions for the Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis

Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)